A detailed history of Round Rock Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Round Rock Advisors, LLC holds 20,713 shares of ABBV stock, worth $3.64 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
20,713
Previous 20,761 0.23%
Holding current value
$3.64 Million
Previous $3.56 Million 14.89%
% of portfolio
0.96%
Previous 0.87%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$163.84 - $199.33 $7,864 - $9,567
-48 Reduced 0.23%
20,713 $4.09 Million
Q2 2024

Aug 02, 2024

BUY
$154.79 - $180.76 $121,200 - $141,535
783 Added 3.92%
20,761 $3.56 Million
Q1 2024

Apr 24, 2024

BUY
$159.82 - $182.1 $3.19 Million - $3.64 Million
19,978 New
19,978 $3.64 Million
Q4 2023

Jan 29, 2024

BUY
$137.6 - $154.97 $3.24 Million - $3.65 Million
23,558 New
23,558 $3.65 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Round Rock Advisors, LLC Portfolio

Follow Round Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Round Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Round Rock Advisors, LLC with notifications on news.